XML 35 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Segment Reporting (Tables) | 12 Months Ended
--- | ---
Jan. 31, 2023
Segment Reporting [Abstract] |
Schedule of net sales and property and equipment |
|  | January 31, |
|  | 2023 |  |  | 2022 |
Net sales |  |  |  |  |  |
Pocono Pharmaceuticals |  | $ | 1,785,597 |  |  | $ | 1,179,620 |
4P Therapeutics |  |  | 294,102 |  |  |  | 242,534 |
|  |  | 2,079,699 |  |  |  | 1,422,154 |
Gross profit |  |  |  |  |  |  |  |
Pocono Pharmaceuticals |  |  | 726,702 |  |  |  | 595,087 |
4P Therapeutics |  |  | 23,702 |  |  |  | (40,777 | )
|  |  | 750,404 |  |  |  | 554,310 |
Operating expenses |  |  |  |  |  |  |  |
Selling, general and administrative-Pocono Pharmaceuticals |  |  | 577,930 |  |  |  | 556,204 |
Selling, general and administrative-4P Therapeutics |  |  | 103,181 |  |  |  | 96,079 |
Corporate overhead |  |  | 3,234,930 |  |  |  | 3,370,541 |
Research and development-4P Therapeutics |  |  | 982,227 |  |  |  | 411,383 |
Goodwill impairment-Pocono Pharmaceuticals |  |  | 327,326 |  |  |  | 2,180,836 |
|  |  | 5,225,594 |  |  |  | 6,615,043 |
Depreciation and Amortization |  |  |  |  |  |  |  |
Pocono Pharmaceuticals |  | $ | 264,156 |  |  | $ | 220,524 |
4P Therapeutics |  |  | 65,987 |  |  |  | 88,217 |
|  | $ | 330,143 |  |  | $ | 308,741 |
Schedule of net sales and property and equipment |
|  | Year Ended |
|  | January 31, |
|  | 2023 |  |  | 2022 |
Net sales: |  |  |  |  |  |
United States |  | $ | 2,079,699 |  |  | $ | 1,335,554 |
Outside the United States |  |  | - |  |  |  | 86,600 |
|  | $ | 2,079,699 |  |  | $ | 1,422,154 |
Property and equipment, net of accumulated depreciation |  |  |  |  |  |  |  |
United States |  | $ | 897,735 |  |  | $ | 979,297 |
Outside the United States |  |  | - |  |  |  | - |
|  | $ | 897,735 |  |  | $ | 979,297 |
Assets: |  |  |  |  |  |  |  |
Corporate |  | $ | 1,745,731 |  |  | $ | 4,750,937 |
Pocono Pharmaceuticals |  |  | 5,400,814 |  |  |  | 5,639,178 |
4P Therapeutics |  |  | 2,309,832 |  |  |  | 2,349,548 |
|  | $ | 9,456,377 |  |  | $ | 12,739,660 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration